REFERENCES
- Kalant H. The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. CMAJ 2001; 165: 917–928
- Ghuran A, Nolan J. Recreational drug misuse: issues for the cardiologist. Heart 2000; 83: 627–633
- Lester SJ, Baggott M, Welm S, et al. Cardiovascular effects of 3,4-methylenedioxymethamphetamine. Ann Intern Med 2000; 133: 969–973
- Mas M, Farré M, de la Torre R, et al. Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans. J Pharmacol Exp Ther 1999; 290: 136–145
- Badon LA, Hicks A, Lord K, et al. Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of ecstasy. J Pharmacol Exp Ther 2002; 302: 898–907
- Milroy CM, Clark JC, Forrest AR. Pathology of deaths associated with “ecstasy” and “eve” misuse. J Clin Pathol 1996; 49: 149–153
- Suarez RV, Riemersma R. “Ecstasy” and sudden cardiac death. Am J Forensic Med Pathol 1988; 9: 339–341
- Dowling GP, McDonough ET, 3rd, Bost RO. ‚Eve’ and ‚Ecstasy’. A report of five deaths associated with the use of MDEA and MDMA. JAMA 1987; 257: 1615–1617
- Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol 2002; 42: 58S–63S
- Fisher BA, Ghuran A, Vadamalai V, et al. Cardiovascular complications induced by cannabis smoking: a case report and review of the literature. Emerg Med J 2005; 22: 679–680
- Aryana A, Williams MA. Marijuana as a trigger of cardiovascular events: Speculation or scientific certainty?. Int J Cardiol 2007; 118: 141–144
- Lindsay AC, Foale RA, Warren O, et al. Cannabis as a precipitant of cardiovascular emergencies. Int J Cardiol 2005; 105: 230–232
- Johnson S, Domino EF. Some cardiovascular effects of marihuana smoking in normal volunteers. Clin Pharmacol Ther 1971; 12: 762–768
- Rezkalla SH, Sharma P, Kloner RA. Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med 2003; 42: 365–369
- Graham AA, Handelsman H. Signal-averaged electrocardiography. Agency for Health Care Policy and Research. Health Technol Assess, Rockville, MD, 98–0020[11], i-15. 1998.
- Cain ME, Anderson J, Arnsdorf M, et al. Signal-averaged electrocardiography. J Am Coll Cardiol 1996; 27: 238–249
- Timmermans C, Ector H, Haisty KW, et al. Signal-averaged ECG parameters in cardiac normals using Frank lead system and Fourier transform filter and gender specific differences: a multicenter study. Pacing Clin Electrophysiol 1994; 17: 303–311
- Yang TF, Macfarlane PW. New sex dependent normal limits of the signal averaged electrocardiogram. Br Heart J 1994; 72: 197–200
- Lalani AP, Kanna B, John J, et al. Abnormal signal-averaged electrocardiogram (SAECG) in obesity. Obes Res 2000; 8: 20–28
- Raineri AA, Traina M, Rotolo A, et al. Quantitative analysis of ventricular late potentials in healthy subjects. Am J Cardiol 1990; 66: 1359–1362
- Bassleer B, Ibrahim T, Friart J. Quantitative analysis of ventricular late potentials (LP) in healthy subjects; comparative study with Holter monitoring. Acta Cardiol 1992; 47: 435–443
- Lander P, Berbari EJ. Principles and signal processing techniques of the high-resolution electrocardiogram. Prog Cardiovasc Dis 1992; 35: 169–188
- Haberl R, Steinbigler P, Jilge G. Spectral analysis of the high resolution ECG: current concepts and future directions. Pacing Clin Electrophysiol 1994; 17: 446–450
- Cheng J. Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human. Fundam Clin Pharmacol 2006; 20: 1–8
- Bailey MS, Curtis AB. The effects of hormones on arrhythmias in women. Curr Womens Health Rep 2002; 2: 83–88
- Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987; 317: 1098–88